Search results
Results from the WOW.Com Content Network
Cervical cancer is the 12th-most common cancer in women in the UK (around 3,100 women were diagnosed with the disease in 2011), and accounts for 1% of cancer deaths (around 920 died in 2012). [152] With a 42% reduction from 1988 to 1997, the NHS-implemented screening programme has been highly successful, screening the highest-risk age group (25 ...
In many developing countries cancer incidence, insofar as this can be measured, appears much lower, most likely because of the higher death rates due to infectious disease or injury. With the increased control over malaria and tuberculosis in some Third World countries, incidence of cancer is expected to rise.
Gynecologic cancer is a type of cancer that affects the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. Gynecological cancers comprise 10-15% of women's cancers, mainly affecting women past reproductive age but posing threats to fertility for younger patients. [ 1 ]
Older women may also be underestimating their risk. Cervical cancer is most frequently diagnosed in women between the ages of 35 and 44, with the average age at diagnosis being 50, notes Diemert ...
By 2024, the number of cancer patients had risen to 42,288, which was a 7% increase from 39,521 in 2021. The numbers increased steadily from 40,435 in 2022 to 41,337 in 2023. [33] In February 2013, there were 90 cancer patients for every 100,000 people in Punjab, which was higher than the national average of 80.
Additionally, problems with India's health care infrastructure prevent adequate screenings and access for women, ultimately leading to lower health outcomes compared to more developed countries. [25] As of 2012, India has a shortage of trained oncologists and cancer centres, further straining the health care system. [24]
Cervical cancer is among the most common cancers worldwide, causing an estimated 604,000 new cases and 342,000 deaths in 2020. [1] About 90% of these new cases and deaths of cervical cancer occurred in low- and middle-income countries, where screening tests and treatment of early cervical cell changes are not readily available. [1]
If all cancer patients survived and cancer occurred randomly, the normal lifetime odds of developing a second primary cancer (not the first cancer spreading to a new site) would be one in nine. [29] However, cancer survivors have an increased risk of developing a second primary cancer, and the odds in 2003 were about one in 4.5. [29]